Amarantus BioScience Short Interest Ratio and Short Volume

0.00 (-4.55 %)
(As of 04/15/2021 03:17 PM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.01
52-Week Range
Now: $0.01
Volume574,347 shs
Average Volume788,894 shs
Market Capitalization$3.87 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

Amarantus BioScience (OTCMKTS:AMBS) Short Interest Data

Current Short Volume22,000 shares
Previous Short Volume12,500 shares
Change Vs. Previous Month:+76.00%
Dollar Volume Sold Short$248.60
Short Interest Ratio / Days to Cover0.0
Last Record DateMarch, 31 2021
Outstanding Shares368,407,000 shares
Percentage of Shares Shorted0.01%
Today's Trading Volume574,347 shares
Average Trading Volume788,894 shares
Today's Volume Vs. Average-27.20%

Short Interest Over Time

Amarantus BioScience (OTCMKTS:AMBS) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202122,000 shares $248.60 +76.0%N/A0 $0.01
3/15/202112,500 shares $177.50 -75.4%N/A0 $0.01
2/26/202150,700 shares $702.70 +40.1%N/A0.1 $0.01
2/12/202136,200 shares $543.00 -12.8%N/A0 $0.02
1/29/202141,500 shares $361.05 No ChangeN/A0 $0.01
1/15/202162,200 shares $547.36 +230.9%N/A0.1 $0.01
12/31/202062,200 shares $416.74 +230.9%N/A0.1 $0.01
12/15/202062,200 shares $441.62 +230.9%N/A0.1 $0.01
11/30/202018,800 shares $188.00 -85.3%N/A0 $0.01
11/15/2020127,900 shares $1,279.00 +6.0%N/A0.1 $0.01
10/30/2020120,700 shares $1,207.00 No ChangeN/A0.1 $0.01
9/30/202083,300 shares $833.00 +304.4%N/A0.1 $0.01
9/15/202020,600 shares $206.00 -74.3%N/A0 $0.01

Amarantus BioScience (OTCMKTS:AMBS) Short Interest FAQ

speech bubbles
speech bubbles

What is Amarantus BioScience's current short interest?

Short interest is the volume of Amarantus BioScience shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 22,000 shares of AMBS short.

Is Amarantus BioScience's short interest increasing or decreasing?

Amarantus BioScience saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 22,000 shares, an increase of 76.0% from the previous total of 12,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Amarantus BioScience's short interest compare to its competitors?

0.00% of Amarantus BioScience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Amarantus BioScience: Intec Pharma Ltd (13.87%), Medicure Inc. (0.00%), Teligent, Inc. (3.87%), CannaPharmaRX, Inc. (0.00%), iCo Therapeutics Inc. (0.00%), BetterLife Pharma Inc. (0.00%), Tower One Wireless Corp. (0.00%), Nexien BioPharma, Inc. (0.00%), GlobeImmune, Inc. (0.00%), and ULURU Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Amarantus BioScience stock?

Short selling AMBS is an investing strategy that aims to generate trading profit from Amarantus BioScience as its price is falling. Amarantus BioScience's stock is trading down $0.00 today. To short Amarantus BioScience stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Amarantus BioScience will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Amarantus BioScience?

A short squeeze for Amarantus BioScience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMBS, which in turn drives the price of the stock up even further.

How often is Amarantus BioScience's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMBS, twice per month. The most recent reporting period available is March, 31 2021.

This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.